Tag: Tailored Covalency platform

Sanofi to acquire US biopharma company Principia Biopharma for $3.7bn

pharmanewsdaily- August 17, 2020

Sanofi acquisition of Principia Biopharma : French pharma giant Sanofi has signed an all-cash deal worth $3.68 billion to acquire Principia Biopharma, a late-stage California-based ... Read More